Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M82.2Revenue $M0.3Net Margin (%)-11,862.9Z-Score12.8
Enterprise Value $M-25.2EPS $-1.0Operating Margin %-10,805.1F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-10,596.0Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %0Quick Ratio37.1Cash flow > EarningsN
Price/Sales2995-y EBITDA Growth Rate %0Current Ratio37.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-27.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.8ROI % (ttm)-24.7Gross Margin Increase y-yN

Gurus Latest Trades with TRGT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TRGTGeorge Soros 2014-09-30 Sold Out $2.49 - $4.66
($3.11)
$ 2.39-30%Sold Out0
TRGTGeorge Soros 2014-06-30 Buy $3.61 - $4.79
($4.14)
$ 2.39-73%New holding13,800
TRGTJean-Marie Eveillard 2012-12-31 Sold Out -0.01%$3.99 - $4.78
($4.43)
$ 2.39-85%Sold Out0
TRGTJean-Marie Eveillard 2012-09-30 Reduce-0.01%$4.22 - $5.12
($4.54)
$ 2.39-90%Reduce -58.86%600,000
TRGTSeth Klarman 2012-03-31 Sold Out -1%$5.03 - $7.5
($5.92)
$ 2.39-148%Sold Out0
TRGTJean-Marie Eveillard 2012-03-31 Add0.02%$5.03 - $7.5
($5.92)
$ 2.39-148%Add 584.30%1,368,600
TRGTSeth Klarman 2011-12-31 Buy 1%$4.99 - $19.25
($11.54)
$ 2.39-383%New holding6,000,000
TRGTJean-Marie Eveillard 2011-12-31 Buy $4.99 - $19.25
($11.54)
$ 2.39-383%New holding200,000
TRGTJean-Marie Eveillard 2009-09-30 Sold Out $2.37 - $21.29
($12.04)
$ 2.39-404%Sold Out0
TRGTJean-Marie Eveillard 2009-06-30 Add$2.35 - $3.59
($2.93)
$ 2.39-23%Add 93.80%121,302
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TRGT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


TRGT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hodges Mauri KVP, Fin. & Admin., CFO, Treas. 2014-12-11Sell0$0 view
Hodges Mauri KVP, Fin. & Admin., CFO, Treas. 2014-12-11Sell0$0 view
SANDELL SCOTT D10% Owner 2013-12-05Sell1,000$5.13-53.22 view
BARRIS PETER J10% Owner 2013-12-05Sell1,000$5.13-53.22 view
BARRETT M JAMES10% Owner 2013-12-05Sell16,000$5.37-55.31 view
SANDELL SCOTT D10% Owner 2013-11-21Sell5,333$5.16-53.49 view
BARRIS PETER J10% Owner 2013-11-21Sell5,333$5.16-53.49 view
BARRETT M JAMES10% Owner 2013-11-21Sell5,333$5.16-53.49 view
BROWN JULIA RDirector 2013-05-10Buy6,000$5.09-52.85 view
HILL STEPHEN APresident and CEO 2013-03-11Buy20,000$4.43-45.82 view

Press Releases about TRGT :

    Quarterly/Annual Reports about TRGT:

    News about TRGT:

    Articles On GuruFocus.com
    Weekly Three-Year Low Highlights: ESIO, VJET, TRGT, ZX May 13 2014 
    Why Should You Invest Only in High-Quality Companies? Jun 13 2012 
    Seth Klarman Buys 25.5 Million Shares of Global Media Conglomerate Vivendi Apr 17 2012 
    Seth Klarman Gives Up Targacept; Sold Out Apr 10 2012 
    4 Mar 20 2012 
    6 Feb 11 2012 
    Seth Klarman Latest Portfolio: Buys IDIX, NG, ANV, Sells PDLI, ALR, BBEP Feb 10 2012 
    Seth Klarman Feb 09 2012 
    comment on TRGT Dec 28 2011 
    comment on TRGT Dec 28 2011 


    More From Other Websites
    The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead -... Apr 09 2015
    Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog Apr 07 2015
    TARGACEPT INC Files SEC form 8-K, Other Events Apr 06 2015
    TARGACEPT INC Financials Mar 21 2015
    TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 17 2015
    TARGACEPT INC Files SEC form 10-K, Annual Report Mar 16 2015
    TARGACEPT INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 06 2015
    Targacept to merge with Catalyst Biosciences Mar 06 2015
    March 5, 2015 Targacept and Catalyst Biosciences Enter Definitive Merger Agreement Creating a... Mar 05 2015
    Targacept and Catalyst Biosciences Enter Definitive Merger Agreement Creating a Protease-Based... Mar 05 2015
    TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Dec 16 2014
    TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 14 2014
    TARGACEPT INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
    November 5, 2014 Targacept Reports Third Quarter 2014 Financial Results Nov 05 2014
    TARGACEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 05 2014
    Targacept Reports Third Quarter 2014 Financial Results Nov 05 2014
    October 29, 2014 Targacept to Report Third Quarter 2014 Financial Results on November 5, 2014 Oct 29 2014
    Targacept to Report Third Quarter 2014 Financial Results on November 5, 2014 Oct 29 2014
    Targacept's Nine-Year Association with AstraZeneca to End Oct 13 2014
    TARGACEPT INC Files SEC form 8-K, Termination of a Material Definitive Agreement Oct 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK